Literature DB >> 8712176

Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered.

N S Goldstein1, W Sanford, M Coffey, L J Layfield.   

Abstract

Recovery of pericolorectal lymph nodes from colectomy specimens has long been part of colorectal cancer staging. Recently, adjuvant therapy has been added for high stage carcinomas, providing further impetus for performing careful lymph node dissections. Pericolorectal lymph nodes were examined to determine if there has been a change over time in the number of lymph nodes recovered and proportion of specimens with pericolonic lymph node metastases from colorectal carcinoma resection specimens. Also, the authors attempted to establish a recommendation for a minimum number of lymph nodes that should be recovered before a colon can be considered free of metastases. Slides and reports of the first 20 consecutive pT3 colorectal carcinoma resections in each year from 1955 to 1995 at William Beaumont Hospital that did not have known metastases at the time of surgery were reviewed (750 specimens total). The mean number of lymph nodes recovered per specimen and incidence of detected lymph node metastases increased over the 41-year period, with the greatest increase occurring during 1992-1995. The greatest proportion of patients with lymph node metastases detected occurred in the 17 to 20 lymph nodes recovered per specimen group. Specimens with more than 20 lymph nodes did not have a higher proportion of lymph node metastases detected compared to specimens with 17 to 20 lymph nodes. Approximately 20% of the specimens with metastases had more than 17 lymph nodes recovered. These results suggest that pathologists should retrieve all the lymph nodes that can be recovered, but at least 17 lymph nodes should be recovered to insure accurate documentation of nodal metastases when present.

Entities:  

Mesh:

Year:  1996        PMID: 8712176     DOI: 10.1093/ajcp/106.2.209

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  80 in total

1.  The influence of nodal size on the staging of colorectal carcinomas.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

Review 2.  Nodal staging of colorectal carcinomas and sentinel nodes.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2003-05       Impact factor: 3.411

3.  Lymph node harvest in colon and rectal cancer: Current considerations.

Authors:  James R McDonald; Andrew G Renehan; Sarah T O'Dwyer; Najib Y Haboubi
Journal:  World J Gastrointest Surg       Date:  2012-01-27

4.  Can adequate lymphadenectomy be obtained by laparoscopic resection in rectal cancer? Results of a case-control study in 200 patients.

Authors:  Samer Sara; Gilles Poncet; David Voirin; Marie-Hélène Laverriere; Daniel Anglade; Jean-Luc Faucheron
Journal:  J Gastrointest Surg       Date:  2010-05-26       Impact factor: 3.452

5.  Robotic left colon cancer resection: a dual docking technique that maximizes splenic flexure mobilization.

Authors:  Sung Uk Bae; Se Jin Baek; Hyuk Hur; Seung Hyuk Baik; Nam Kyu Kim; Byung Soh Min
Journal:  Surg Endosc       Date:  2014-08-27       Impact factor: 4.584

6.  Ex Vivo Intra-arterial Methylene Blue Injection in Rectal Cancer Specimens Increases the Lymph-Node Harvest, Especially After Preoperative Radiation.

Authors:  Maria Münster; Uwe Hanisch; Muin Tuffaha; Rainer Kube; Henry Ptok
Journal:  World J Surg       Date:  2016-02       Impact factor: 3.352

Review 7.  Colorectal cancer and lymph nodes: the obsession with the number 12.

Authors:  Giovanni Li Destri; Isidoro Di Carlo; Roberto Scilletta; Beniamino Scilletta; Stefano Puleo
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

8.  Local recurrence after rectal cancer treatment in Manitoba.

Authors:  Steven Latosinsky; Donna Turner
Journal:  Can J Surg       Date:  2009-02       Impact factor: 2.089

9.  Is adjuvant chemotherapy beneficial to high risk stage II colon cancer? Analysis in a single institute.

Authors:  Chun-Chi Lin; Jen-Kou Lin; Shih-Ching Chang; Huann-Sheng Wang; Shung-Haur Yang; Jeng-Kai Jiang; Wei-Shone Chen; Tzu-Chen Lin
Journal:  Int J Colorectal Dis       Date:  2009-02-24       Impact factor: 2.571

10.  Clinical and oncologic outcomes of totally robotic total mesorectal excision for rectal cancer: initial results in a center for minimally invasive surgery.

Authors:  Chang-Nam Kim; Sung Uk Bae; Seul-Gi Lee; Seung Hyun Yang; In Gun Hyun; Je Ho Jang; Byung Sun Cho; Joo Seung Park
Journal:  Int J Colorectal Dis       Date:  2016-03-09       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.